Nevertheless, in breast cancer, PHLDA1 could negatively regulate Aurora A and antagonize Aurora A-mediated oncogenic pathways, and decreased PHLDA1 expression was associated with poorer prognosis [14, 15]. Here, PHLDA1 is linked to breast carcinoma.